Healthcare entity

Dr. Reddy's Laboratories

Company

Every one of those 2 sits in a single category, market-trends. Eli Lilly is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Their average consequence score of 8 runs above the beat's 6.1 for that window.

Last mentioned: Jul 27, 2026

Entity pulse

Recent coverage · Dr. Reddy's Laboratories

2 stories
8 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Dr. Reddy's Laboratories

Every one of those 2 sits in a single category, market-trends. Eli Lilly is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Their average consequence score of 8 runs above the beat's 6.1 for that window. They are less corroborated than the beat average, carrying 2.5 original sources each against 2.8 for the same window. We currently track 2 Healthcare stories that mention Dr. Reddy's Laboratories, published between March 20, 2026 and March 25, 2026.

Stories tracked
2
Sources per story
2.5

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 125 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Dr. Reddy's Laboratories. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Dr. Reddy's Laboratories 2

Dr. Reddy's Laboratories is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.